Trial · NCT03518034
Trial comparisons13
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
1 to 13 of 13
Download this page as JSON| Comparison | Source |
|---|---|
| AndroGel 1.62% vs Placebo: Tertiary Endpoint: Incidence Rate of Heart Failure | Trial comparisons |
| AndroGel 1.62% vs Placebo: Tertiary Endpoint: Incidence Rate of All Cause Mortality | Trial comparisons |
| AndroGel 1.62% vs Placebo: Tertiary Endpoint: Incidence Rate of Prostate Cancer | Trial comparisons |
| AndroGel 1.62% vs Placebo: Time From Randomization to the First Component Event of Major Adverse Cardiac Event (MACE): Number and Percentage of Participants With an Event | Trial comparisons |
| AndroGel 1.62% vs Placebo: Tertiary Endpoint: Incidence Rate of Acute Urinary Retention | Trial comparisons |
| AndroGel 1.62% vs Placebo: Time From Randomization to First Clinical Fracture: Number and Percentage of Participants With an Event | Trial comparisons |
| AndroGel 1.62% vs Placebo: Tertiary Endpoint: Incidence Rate of Pharmacologic Treatment for Lower Urinary Tract Symptoms | Trial comparisons |
| AndroGel 1.62% vs Placebo: Tertiary Endpoint: Incidence Rate of Peripheral Arterial Revascularization | Trial comparisons |
| AndroGel 1.62% vs Placebo: Tertiary Endpoint: Incidence Rate of Invasive Prostate Surgical Procedures for Benign Prostatic Hyperplasia | Trial comparisons |
| AndroGel 1.62% vs Placebo: Incidence of High-Grade Prostate Cancer | Trial comparisons |
| AndroGel 1.62% vs Placebo: Time From Randomization to the First Component Event of CV Safety Endpoint: Number and Percentage of Participants With an Event | Trial comparisons |
| AndroGel 1.62% vs Placebo: Tertiary Endpoint: Incidence Rate of Prostate Biopsy | Trial comparisons |
| AndroGel 1.62% vs Placebo: Tertiary Endpoint: Incidence Rate of Venous Thromboembolic Events | Trial comparisons |
trials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03518034/comparisons